Profile

Avalon BioVentures is a venture capital firm based in La Jolla, California, specializing in biotech investments. Established over 40 years ago, the firm is led by Managing Partners Jay B. Lichter, Ph.D., Sanford J. Madigan, Ph.D., and Sergio G. Duron, Ph.D., who bring decades of experience in scientific research, operational management, and biotech investments. Avalon is known for its hands-on approach to nurturing early-stage biotech companies, providing operational support, strategic guidance, and leveraging their ABV Accelerator for company growth.

Avalon BioVentures focuses on pioneering life sciences and biotechnology, investing in early-stage developments and transformative therapeutic solutions. Their investment strategy includes identifying and developing disruptive biotech technologies, often partnering with world-class scientists and academic institutions. The firm typically invests in the pre-seed to Series A stage with a focus primarily on North America. In addition to the newly announced $200m Avalon BioVentures II, their investment history includes other successful fund iterations.

Notable portfolio companies include Janux Therapeutics - cancer immunotherapy, Synthorx - protein therapeutics (acquired by Sanofi for $2.5 billion), and Fortis Therapeutics - cancer treatments. Avalon’s approach involves not just financing but also participating in the corporate governance and strategic decisions of its portfolio companies, driving them towards successful exits like IPOs and acquisitions.

Industry

Biotechnology MedTech Life Sciences HealthTech

Avalon BioVentures Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Avalon BioVentures II, LP
Venture Capital (VC)
Biotechnology
Pre-seed
Seed
Series A
North America
$1-5 m
$200 M
November 2026

Contacts

Name
Title
Email
avatar
Tighe M. Reardon, CPA Chief Financial Officer & Managing Partner
Chief Financial Officer & Managing Partner
t•••@•••
avatar
Sanford J. Madigan, Ph.D. Partner
Partner
s•••@•••
Upgrade to see contacts
avatar
jBUfvQgK538bWpXo jBUfvQgK538bWpXo
jBUfvQgK538bWpXo
avatar
jBUfvQgK538bWpXo jBUfvQgK538bWpXo
jBUfvQgK538bWpXo
avatar
jBUfvQgK538bWpXo jBUfvQgK538bWpXo
jBUfvQgK538bWpXo
Investment-team contacts for Avalon BioVentures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Avalon BioVentures

Avalon BioVentures is a venture capital firm. It backs companies at Pre-seed, Seed and Series A, writing tickets of $1-5 m.
Avalon BioVentures is located in La Jolla, California, United States.
Avalon BioVentures was founded in 1986.
Avalon BioVentures invests in companies and startups in Biotechnology, MedTech, Life Sciences, HealthTech.
Avalon BioVentures invests in companies and startups in North America.
Avalon BioVentures invests in companies and startups at Pre-seed, Seed, Series A.
Avalon BioVentures usually invests $1-5 m on average.
Avalon BioVentures last fund was created/launched in 2026-11-18
Avalon BioVentures can be reached through its website avalonbioventures.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Avalon BioVentures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Avalon BioVentures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 19 November, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.